Fragmented regulations, IP protection gaps, and language barriers hinder cell and gene therapy adoption across Europe's 27 ...
CEPI uses AI to achieve its vaccine goal, aiming to develop safe, effective vaccines within 100 days of identifying pandemic ...
An expert from Northway Biotech and Lithuania’s Minister of Economy and Innovation talk about how the country is poised to be ...
AI-driven functional precision medicine could transform cancer care by testing live tumor cells to deliver personalized, ...
Rather than relying on technological novelty, emerging biotechs must leverage strategic content and marketing intelligence to ...
Novartis breaks ground on Denton, Texas RLT facility, set to open in 2028. The site advances the firm's $23bn US ...
The Amgen investment will bring Puerto Rico's biomanufacturing facility commitment to nearly $1 billion, reinforcing US ...
Ecolab opens Asia bioprocessing facility in South Korea, offering downstream process development support to biopharmaceutical ...
Switzerland's DINAMIQS receives Swissmedic approval for GMP viral vector production, becoming the country's first fully ...
Blood centers are scaling cell and gene therapies by leveraging decades of expertise in apheresis, logistics, and quality ...
Novartis announces a new API facility in Morrisville, NC, as part of its $23bn US manufacturing expansion, boosting biopharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results